The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

L. K. Tsoi; V. N. Bogatyrev; V. P. Letyagin; Ya. V. Vishnevskaya; A. M. Platova

doi:10.17650/1994-4098-2010-0-2-44-46

Опухоли женской репродуктивной системы (Aug 2014)

The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

L. K. Tsoi,
V. N. Bogatyrev,
V. P. Letyagin,
Ya. V. Vishnevskaya,
A. M. Platova

Affiliations

L. K. Tsoi: N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
V. N. Bogatyrev: N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
V. P. Letyagin: N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Ya. V. Vishnevskaya: N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
A. M. Platova: N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

DOI: https://doi.org/10.17650/1994-4098-2010-0-2-44-46
Journal volume & issue: Vol. 0, no. 2
pp. 44 – 46

Abstract

Read online

The determination of mutant p53 and the basic parameters studied by DNA-flow cytofluorometry in combination with other clinical and morphological predictors may be used as additional prognostic criteria individually in each patient with breast cancer.

Published in Опухоли женской репродуктивной системы

ISSN: 1994-4098 (Print); 1999-8627 (Online)
Publisher: ABV-press
Country of publisher: Russian Federation
LCC subjects: Medicine: Gynecology and obstetrics
Website: http://ojrs.abvpress.ru/

About the journal

Abstract

Keywords